Benzenesulfonamides: a unique class of chemokine receptor type 4 inhibitors.
Suazette Reid Mooring, Jin Liu, Zhongxing Liang, Jeffrey Ahn, Samuel Hong, Younghyoun Yoon, James P Snyder, Hyunsuk Shim
文献索引:ChemMedChem 8(4) , 622-32, (2013)
全文:HTML全文
摘要
The interaction of CXCR4 with CXCL12 (SDF-1) plays a critical role in cancer metastasis by facilitating the homing of tumor cells to metastatic sites. Based on our previously published work on CXCR4 antagonists, we have synthesized a series of aryl sulfonamides that inhibit the CXCR4/CXCL12 interaction. Analogue bioactivities were assessed with binding affinity and Matrigel invasion assays. Computer modeling was employed to evaluate a selection of the new analogues docked into the CXCR4 X-ray structure and to rationalize discrepancies between the affinity and Matrigel in vitro assays. A lead compound displays nanomolar potency in the binding affinity assay (IC(50)=8.0 nM) and the Matrigel invasion assay (100 % blockade of invasion at 10 nM). These data demonstrate that benzenesulfonamides are a unique class of CXCR4 inhibitors with high potency.Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
相关化合物
相关文献:
2014-09-26
[J. Chromatogr. A. 1361 , 265-76, (2014)]
2014-10-01
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 968 , 105-11, (2014)]
2015-01-01
[Nat. Commun. 6 , 5912, (2015)]
2014-10-15
[Eur. J. Pharm. Sci. 63 , 14-21, (2014)]
2015-08-01
[Food Funct. 6 , 2598-606, (2015)]